These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer. Loos M; Giese NA; Kleeff J; Giese T; Gaida MM; Bergmann F; Laschinger M; W Büchler M; Friess H Cancer Lett; 2008 Sep; 268(1):98-109. PubMed ID: 18486325 [TBL] [Abstract][Full Text] [Related]
24. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. Thompson RH; Webster WS; Cheville JC; Lohse CM; Dong H; Leibovich BC; Kuntz SM; Sengupta S; Kwon ED; Blute ML Urology; 2005 Nov; 66(5 Suppl):10-4. PubMed ID: 16194701 [TBL] [Abstract][Full Text] [Related]
25. PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Crane CA; Panner A; Murray JC; Wilson SP; Xu H; Chen L; Simko JP; Waldman FM; Pieper RO; Parsa AT Oncogene; 2009 Jan; 28(2):306-12. PubMed ID: 18850006 [TBL] [Abstract][Full Text] [Related]
26. Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma. Karim R; Jordanova ES; Piersma SJ; Kenter GG; Chen L; Boer JM; Melief CJ; van der Burg SH Clin Cancer Res; 2009 Oct; 15(20):6341-7. PubMed ID: 19825956 [TBL] [Abstract][Full Text] [Related]
27. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells. Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469 [TBL] [Abstract][Full Text] [Related]
29. B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection. Wang X; Zhang Z; Zhang S; Fu J; Yao J; Jiao Y; Wu H; Wang FS Eur J Immunol; 2008 Nov; 38(11):3226-36. PubMed ID: 18924219 [TBL] [Abstract][Full Text] [Related]
30. [Role of B7-H1 in pancreatic carcinoma immune evasion]. Huang DS; Liu JW; Geng L; Jiang GP; Shen GL; Yao WF Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(4):282-5. PubMed ID: 19570392 [TBL] [Abstract][Full Text] [Related]
31. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor. Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206 [TBL] [Abstract][Full Text] [Related]
32. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Blank C; Mackensen A Cancer Immunol Immunother; 2007 May; 56(5):739-45. PubMed ID: 17195077 [TBL] [Abstract][Full Text] [Related]
33. B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin. Cao Y; Zhang L; Kamimura Y; Ritprajak P; Hashiguchi M; Hirose S; Azuma M Cancer Res; 2011 Feb; 71(4):1235-43. PubMed ID: 21159661 [TBL] [Abstract][Full Text] [Related]
34. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412 [TBL] [Abstract][Full Text] [Related]